{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:19:37Z","timestamp":1793740777433,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003558","name":"Ministry of Justice","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003558","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2022YFC3302003"],"award-info":[{"award-number":["2022YFC3302003"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Development Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jpba.2025.116824","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T03:55:16Z","timestamp":1742270116000},"page":"116824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Chiral analysis of ketamine enantiomers in human urine and hair: Application to authentic cases of ketamine use"],"prefix":"10.1016","volume":"261","author":[{"given":"Zhen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hejian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3237-108X","authenticated-orcid":false,"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpba.2025.116824_bib1","first-page":"46","article-title":"An investigation of ketamine on abuse and harm","volume":"25","author":"Li","year":"2016","journal-title":"Chin. J. Drug Depend."},{"issue":"1","key":"10.1016\/j.jpba.2025.116824_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1025055109480","article-title":"The ketamine model of the near-death experience: a central role for the N-methyl-D-aspartate receptor","volume":"16","author":"Jansen","year":"1997","journal-title":"J. Near-Death Stud."},{"issue":"4","key":"10.1016\/j.jpba.2025.116824_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/13546805.2010.546074","article-title":"Ketamine administration in healthy volunteers reproduces aberrant agency experiences associated with schizophrenia","volume":"16","author":"Moore","year":"2011","journal-title":"Cogn. Neuropsychiatry"},{"issue":"9","key":"10.1016\/j.jpba.2025.116824_bib4","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00213-014-3782-0","article-title":"Chronic administration of ketamine mimics the perturbed sense of body ownership associated with schizophrenia","volume":"232","author":"Tang","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.jpba.2025.116824_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1460-9592.2004.01358.x","article-title":"S-ketamine and s-norketamine plasma concentrations after nasal and i.v. administration in anesthetized children","volume":"14","author":"Weber","year":"2004","journal-title":"Paediatr. Anaesth."},{"issue":"9-10","key":"10.1016\/j.jpba.2025.116824_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00508-017-1299-3","article-title":"S (+)-ketamine: Current trends in emergency and intensive care medicine","volume":"130","author":"Trimmel","year":"2018","journal-title":"Wien. Klin. Woche"},{"key":"10.1016\/j.jpba.2025.116824_bib7","unstructured":"FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor's office or clinic, Food and Drug Administration, 5 March 2019, \u3008https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-nasal-spray-medication-treatment-resistant-depression-available-only-certified\u3009 (accessed 3 March 2025)."},{"issue":"6","key":"10.1016\/j.jpba.2025.116824_bib8","first-page":"339","article-title":"Esketamine (Spravato) for treatment-resistant depression","volume":"101","author":"Jalloh","year":"2020","journal-title":"Am. Fam. Physician"},{"issue":"2-3","key":"10.1016\/j.jpba.2025.116824_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.forsciint.2006.01.018","article-title":"Forensic application of chiral separation of amphetamine-type stimulants to impurity analysis of seized methamphetamine by capillary electrophoresis","volume":"161","author":"Iwata","year":"2006","journal-title":"Forensic Sci. Int."},{"issue":"4","key":"10.1016\/j.jpba.2025.116824_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/jat\/30.4.232","article-title":"High-performance liquid chromatographic-mass spectrometric determination of methamphetamine and amphetamine enantiomers, desmethylselegiline and selegiline, in hair samples of long-term methamphetamine abusers or selegiline users","volume":"30","author":"Nishida","year":"2006","journal-title":"J. Anal. Toxicol."},{"issue":"1-3","key":"10.1016\/j.jpba.2025.116824_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.forsciint.2012.08.036","article-title":"Chemical profiling of seized methamphetamine putatively synthesized from phenylacetic acid derivatives","volume":"227","author":"Tsujikawa","year":"2013","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2025.116824_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.forsciint.2017.01.025","article-title":"Enantioseparation of methamphetamine by supercritical fluid chromatography with cellulose-based packed column","volume":"273","author":"Segawa","year":"2017","journal-title":"Forensic Sci. Int."},{"issue":"5","key":"10.1016\/j.jpba.2025.116824_bib13","first-page":"16","article-title":"Advancements in drug residue analysis techniques in hair","volume":"67","author":"Wei","year":"2023","journal-title":"Metrol. Sci. Technol."},{"issue":"4","key":"10.1016\/j.jpba.2025.116824_bib14","first-page":"60","article-title":"The study of the common drug analysis in hairs","volume":"27","author":"Li","year":"2017","journal-title":"J. Railw. Police Coll."},{"issue":"2","key":"10.1016\/j.jpba.2025.116824_bib15","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0378-4347(95)00545-5","article-title":"Determination of ketamine and norketamine enantiomers in plasma by solid-phase extraction and high-performance liquid chromatography","volume":"678","author":"Svensson","year":"1996","journal-title":"J. Chromatogr. B Biomed. Appl."},{"issue":"2","key":"10.1016\/j.jpba.2025.116824_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0378-4347(00)00331-5","article-title":"Stereoselective high-performance liquid chromatographic determination of ketamine and its active metabolite, norketamine, in human plasma","volume":"746","author":"Yanagihara","year":"2000","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jpba.2025.116824_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpba.2017.02.035","article-title":"Quantitative chiral and achiral determination of ketamine and its metabolites by LC-MS\/MS in human serum, urine and fecal samples","volume":"139","author":"Hasan","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.jpba.2025.116824_bib18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1570-0232(03)00420-3","article-title":"Determination of the enantiomers of ketamine and norketamine in human plasma by enantioselective liquid chromatography-mass spectrometry","volume":"794","author":"Rodriguez Rosas","year":"2003","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2025.116824_bib19","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jpba.2017.09.033","article-title":"A rapid and sensitive chiral LC-MS\/MS method for the determination of ketamine and norketamine in mouse plasma, brain and cerebrospinal fluid applicable to the stereoselective pharmacokinetic study of ketamine","volume":"148","author":"Toki","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.116824_bib20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jpba.2017.09.007","article-title":"Ketamine metabolites with antidepressant effects: fast, economical, and eco-friendly enantioselective separation based on supercritical-fluid chromatography (SFC) and single quadrupole MS detection","volume":"146","author":"Fassauer","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.116824_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.forsciint.2016.06.017","article-title":"Chiral separation and determination of ketamine and norketamine in hair by capillary electrophoresis","volume":"266","author":"Porpiglia","year":"2016","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.jpba.2025.116824_bib22","unstructured":"ANSI\/ASB Standard 036, Standard Practices for Method Validation in Forensic, 2019, \u3008https:\/\/www.aafs.org\/sites\/default\/files\/media\/documents\/036_Std_e1.pdf\u3009(accessed 3 March 2025)."},{"issue":"13","key":"10.1016\/j.jpba.2025.116824_bib23","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.jpba.2025.116824_bib24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","article-title":"Validation of new methods","volume":"165","author":"Peters","year":"2007","journal-title":"Forensic Sci. Int."},{"issue":"7","key":"10.1016\/j.jpba.2025.116824_bib25","first-page":"89","article-title":"Research progress in the analysis of ketamine and its metabolites in biological samples","volume":"48","author":"You","year":"2022","journal-title":"Chem. Eng. Des. Commun."},{"issue":"44","key":"10.1016\/j.jpba.2025.116824_bib26","doi-asserted-by":"crossref","first-page":"6942","DOI":"10.1016\/j.chroma.2010.08.075","article-title":"Reversed-phase chiral HPLC and LC\/MS analysis with tris(chloromethylphenylcarbamate) derivatives of cellulose and amylose as chiral stationary phases","volume":"1217","author":"Peng","year":"2010","journal-title":"J. Chromatogr. A"},{"issue":"1\u20133","key":"10.1016\/j.jpba.2025.116824_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.forsciint.2009.12.027","article-title":"Simultaneous screening and quantification of 52 common pharmaceuticals and drugs of abuse in hair using UPLC-TOF-MS","volume":"196","author":"Nielsen","year":"2010","journal-title":"Forensic Sci. Int."},{"issue":"5","key":"10.1016\/j.jpba.2025.116824_bib28","first-page":"431","article-title":"Stereoselective pharmacokinetics of ketamine: R (-)-ketamine inhibits the elimination of S (+)-ketamine","volume":"70","author":"Ihmsen","year":"2001","journal-title":"Clin. Pharm. Ther."},{"issue":"3","key":"10.1016\/j.jpba.2025.116824_bib29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.tvjl.2007.05.005","article-title":"Stereoselective pharmacokinetics of ketamine and norketamine after racemic ketamine or S-ketamine administration in Shetland ponies sedated with xylazine","volume":"177","author":"Larenza","year":"2008","journal-title":"Vet. J."},{"issue":"9","key":"10.1016\/j.jpba.2025.116824_bib30","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/1522-2683(200205)23:9<1328::AID-ELPS1328>3.0.CO;2-Z","article-title":"The use of a highly sulfated cyclodextrin for the simultaneous chiral separation of amphetamine-type stimulants by capillary electrophoresis","volume":"23","author":"Iwata","year":"2002","journal-title":"Electrophoresis"},{"issue":"1","key":"10.1016\/j.jpba.2025.116824_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.forsciint.2006.10.013","article-title":"Monitoring precursor chemicals of methamphetamine through enantiomer profiling","volume":"173","author":"Lee","year":"2007","journal-title":"Forensic Sci. Int."},{"issue":"4","key":"10.1016\/j.jpba.2025.116824_bib32","first-page":"565","article-title":"Discrimination of synthesizing routines for ketamine,hydroxylimine and o-chlorophenyl cyclopentyl ketone samples using profiling impurities","volume":"40","author":"Fan","year":"2021","journal-title":"J. Instrum. Anal."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525001657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525001657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:16:06Z","timestamp":1762308966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525001657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":32,"alternative-id":["S0731708525001657"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116824","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chiral analysis of ketamine enantiomers in human urine and hair: Application to authentic cases of ketamine use","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116824"}}